Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.560 | ||
| Révision: | $428.37M | $398.26M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.870 | 2.060 | 0.1900 |
| Révision: | $467.54M | $443.25M | $27.82M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.460 | 1.780 | 0.3200 |
| Révision: | $409.93M | $381.69M | $36.80M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.460 | 1.830 | 0.3700 |
| Révision: | $420.85M | $372.31M | $26.45M |
